LexDanaLexDanabeta
Inventor

SHUYA WANG

Inventor
CN

Overview

2→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
A01KAnimal husbandry13%
C12NMicroorganisms or enzymes13%
PatentTitleYear
12,440,572FVIII fusion protein and use thereof202511,471,513Highly glycosylated human blood-clotting factor VIII fusion protein, and manufacturing method and application of same2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to AMPSOURCE BIOPHARMA SHANGHAI INC (1)· patent assignee history
2022Patents assigned to FUREN PHARMACEUTICAL GROUP CO LTD (1)· patent assignee history
2022Patents assigned to Kaifeng pharmaceutical group co ltd (1)· patent assignee history
2022Patents assigned to PHARMAB INC (1)· patent assignee history
2022–2025Based in CN· patent location history
2025Patents assigned to ZHENGZHOU GENSCIENCES INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMPSOURCE BIOPHARMA SHANGHAI INC12022
FUREN PHARMACEUTICAL GROUP CO LTD12022
Kaifeng pharmaceutical group co ltd12022
PHARMAB INC12022
ZHENGZHOU GENSCIENCES INC12025
Locations
LocationPatentsSpan
CN22022–2025